1. Home
  2. PLSE vs WEAV Comparison

PLSE vs WEAV Comparison

Compare PLSE & WEAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLSE
  • WEAV
  • Stock Information
  • Founded
  • PLSE 2014
  • WEAV 2011
  • Country
  • PLSE United States
  • WEAV United States
  • Employees
  • PLSE N/A
  • WEAV N/A
  • Industry
  • PLSE Medical/Dental Instruments
  • WEAV EDP Services
  • Sector
  • PLSE Health Care
  • WEAV Technology
  • Exchange
  • PLSE Nasdaq
  • WEAV Nasdaq
  • Market Cap
  • PLSE 1.2B
  • WEAV 1.1B
  • IPO Year
  • PLSE 2016
  • WEAV 2021
  • Fundamental
  • Price
  • PLSE $19.74
  • WEAV $16.44
  • Analyst Decision
  • PLSE
  • WEAV Strong Buy
  • Analyst Count
  • PLSE 0
  • WEAV 5
  • Target Price
  • PLSE N/A
  • WEAV $16.50
  • AVG Volume (30 Days)
  • PLSE 133.6K
  • WEAV 660.4K
  • Earning Date
  • PLSE 10-30-2024
  • WEAV 02-19-2025
  • Dividend Yield
  • PLSE N/A
  • WEAV N/A
  • EPS Growth
  • PLSE N/A
  • WEAV N/A
  • EPS
  • PLSE N/A
  • WEAV N/A
  • Revenue
  • PLSE N/A
  • WEAV $195,837,000.00
  • Revenue This Year
  • PLSE N/A
  • WEAV $21.45
  • Revenue Next Year
  • PLSE N/A
  • WEAV $16.13
  • P/E Ratio
  • PLSE N/A
  • WEAV N/A
  • Revenue Growth
  • PLSE N/A
  • WEAV 20.54
  • 52 Week Low
  • PLSE $6.60
  • WEAV $8.10
  • 52 Week High
  • PLSE $22.69
  • WEAV $16.56
  • Technical
  • Relative Strength Index (RSI)
  • PLSE 58.11
  • WEAV 63.32
  • Support Level
  • PLSE $17.35
  • WEAV $15.37
  • Resistance Level
  • PLSE $19.90
  • WEAV $16.45
  • Average True Range (ATR)
  • PLSE 1.05
  • WEAV 0.44
  • MACD
  • PLSE 0.15
  • WEAV 0.01
  • Stochastic Oscillator
  • PLSE 80.47
  • WEAV 95.17

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.

About WEAV Weave Communications Inc.

Weave Communications Inc is a customer experience and payments software platform tailored for SMB healthcare businesses, that revolutionizes patient interaction from initial contact to billing. It integrates diverse workflows into a unified solution, minimizing manual tasks and maximizing patient engagement. Weave democratizes enterprise-level communication tools, simplifying them for SMBs in a singular platform. Offering varied communication channels, appointment scheduling, payment processing, and more, it enhances practitioner-patient relationships and optimizes practice operations. The company has a singular operating segment and revenue primarily from subscription services.

Share on Social Networks: